Zenith MD&A posted to SEDAR 8/23/18

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith MD&A posted to SEDAR 8/23/18

posted on Aug 31, 2018 09:09AM

The latest Zenith MD&A was posted to SEDAR 8/23/18. Nothing new at first glance. I'm looking forward to hearing more updates at the AGM.